Masdiagsp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-05-10
Share capital
6 950,00 PLN
Activity description

Masdiag is a diagnostic laboratory that focuses on developing and optimizing diagnostic methods using LC-MS (liquid chromatography-mass spectrometry) and dried blood spot (DBS) samples. They offer innovative diagnostic tests that allow patients to collect samples at home and send them for analysis, with results provided via email. Their services include routine diagnostic tests and customized methodologies for individual clients and businesses.

Registered address
ul. Stefana Żeromskiego 33, 01-882 Warszawa, Poland
Website
masdiag.plWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-30300-31192-WDIBC-12

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.69mMedianUSD 92.16kAverageUSD 1.47m
Net profit
This companyUSD 17.33kMedianUSD 2.46kAverageUSD 170.36k
Operating costs
This companyUSD 1.67mMedianUSD 85.23kAverageUSD 1.19m
Assets
This companyUSD 1.10mMedianUSD 40.76kAverageUSD 1.02m

Bank accounts

Registered as a VAT taxpayer on 2012-12-03. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

16 public aid cases recorded, with a total value of $1,940,936.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$88
Aid for research and development projects: industrial research
$196.6K
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$7,375

European Funds

5 projects co-financed from European Funds recorded, with total EU co-financing of $2,480,725.

ProjectEU co-financing
Kropla dla pamięci - innowacyjny test diagnostyczny pozwalający ocenić ryzyko wystąpienia demencji
$760.5K
Opracowanie metod monitorowania terapii prowadzonych z zastosowaniem preparatów z konopii.
$429.0K
Oznaczanie metali i innych biogennych pierwiastków w materiale biologicznym o potencjale diagnostycznym za pomocą fluorescencyjnego spektrometru rentgenowskiego
$393.9K

Tenders

1 tender recorded as contractor, with a total value of $103,300.

SubjectAmount
Kontrola zawartości tetrahydrokannabinolu (THC) w konopiach włóknistych
$103.3K

Authorized Representatives

Renata Anna Halak — Attorney-in-fact (sole)
Paweł Stanisław Bieńkowski — Attorney-in-fact (sole)
Tomasz Bieńkowski — President of the Management Board
Konrad Piotr Kowalski — Management Board Member
Oktawian Oźminkowski — Attorney-in-fact (sole)

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Elżbieta Wiktoria Bieńkowska (83)
90$1,215.5664.7482%
Oktawian Oźminkowski (56)
39$526.7428.0576%
Others
10$135.067.1942%

Beneficial owners

Person
Elżbieta Wiktoria Bieńkowska (83)
Oktawian Oźminkowski (56)

Subsidiaries

NameStake
61%

Competitors

Name
Warsaw GenomicsS.A.
Prestige Medical Servicessp. z o.o.
Eurodiagnosissp. z o.o.
Ośrodek Diagnostyczny Zdrowe Jelitasp. z o.o.
Alab-Medsp. z o.o.
CM Woroniczasp. z o.o.
Vitaimmun Drobczyńska, Szachtasp. k.
Medic Housesp. z o.o.
Laboratorium Analiz Lekarskich Laborsp. z o.o.
Vivamedsp. z o.o.

Change history

DateEvent
2022-03-08PKD change
2020-02-07Address change
2013-10-15Share capital change
2012-05-10Entered in the register

FAQ

Last updated: 2026-07-15